BIOTECHNOLOGY AND LIFE SCIENCES products beginning with : A
6751 to 6800 of 9097 results Page: 
120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 [136] 137 138 139 140 
120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 [136] 137 138 139 140
Anti-NGAL (2 suppliers)
Anti-NGAL Aptamer-CTApt-482 (1 supplier)
Anti-NGAL Aptamer-CTApt-483 (1 supplier)
Anti-NGAL Aptamer-CTApt-484 (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-MMAF ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-SMCC-DM1 ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-SPDB-DM4 ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-MMAF ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGF (Fulranumab)-SMCC-DM1 ADC (1 supplier)
Anti-NGF (Fulranumab)-SPDB-DM4 ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-MMAF ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGF (Tanezumab)-SMCC-DM1 ADC (1 supplier)
Anti-NGF (Tanezumab)-SPDB-DM4 ADC (1 supplier)
Anti-NGF -MC-MMAF ADC (1 supplier)
Anti-NGF -MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGF -MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGF -MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGF -SMCC-DM1 ADC (1 supplier)
Anti-NGF -SPDB-DM4 ADC (1 supplier)
Anti-Ni2+/sup> Aptamer (1 supplier)
Anti-Nitrosocysteine Antibody (2 suppliers)
Anti-Non-small Cell Lung Cancer Aptamer (NA115) (1 supplier)
Anti-Nontumorigenic HF cell line Aptamer (1 supplier)
Anti-NOTCH1 ((NRR) Neutralizing Antibody (V3S-0522-YC8181) (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-MMAF ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-SMCC-DM1 ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-SPDB-DM4 ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-MMAF ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-SMCC-DM1 ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-SPDB-DM4 ADC (1 supplier)
Anti-NOTCH2 Neutralizing Antibody (V3S-0622-YC3734) (1 supplier)
Anti-NOTCH2 Neutralizing Antibody (V3S-0622-YC5128) (1 supplier)
Anti-NOTCH3-MMAE ADC (1 supplier)
Anti-Notch4 Neutralizing Antibody (V3S-0822-YC2152) (1 supplier)
Anti-NoV GII VP1 Neutralizing Antibody (V3S-0522-YC4189) (1 supplier)
Anti-NGAL Aptamer-CTApt-482 (1 supplier)
Anti-NGAL Aptamer-CTApt-483 (1 supplier)
Anti-NGAL Aptamer-CTApt-484 (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-MMAF ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-SMCC-DM1 ADC (1 supplier)
Anti-NGcGM3 (Racotumomab)-SPDB-DM4 ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-MMAF ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGF (Fulranumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGF (Fulranumab)-SMCC-DM1 ADC (1 supplier)
Anti-NGF (Fulranumab)-SPDB-DM4 ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-MMAF ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGF (Tanezumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGF (Tanezumab)-SMCC-DM1 ADC (1 supplier)
Anti-NGF (Tanezumab)-SPDB-DM4 ADC (1 supplier)
Anti-NGF -MC-MMAF ADC (1 supplier)
Anti-NGF -MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NGF -MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NGF -MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NGF -SMCC-DM1 ADC (1 supplier)
Anti-NGF -SPDB-DM4 ADC (1 supplier)
Anti-Ni2+/sup> Aptamer (1 supplier)
Anti-Nitrosocysteine Antibody (2 suppliers)
Anti-Non-small Cell Lung Cancer Aptamer (NA115) (1 supplier)
Anti-Nontumorigenic HF cell line Aptamer (1 supplier)
Anti-NOTCH1 ((NRR) Neutralizing Antibody (V3S-0522-YC8181) (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-MMAF ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-SMCC-DM1 ADC (1 supplier)
Anti-NOTCH1 (Brontictuzumab)-SPDB-DM4 ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-MMAF ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-SMCC-DM1 ADC (1 supplier)
Anti-NOTCH2 (Tarextumab)-SPDB-DM4 ADC (1 supplier)
Anti-NOTCH2 Neutralizing Antibody (V3S-0622-YC3734) (1 supplier)
Anti-NOTCH2 Neutralizing Antibody (V3S-0622-YC5128) (1 supplier)
Anti-NOTCH3-MMAE ADC (1 supplier)
Anti-Notch4 Neutralizing Antibody (V3S-0822-YC2152) (1 supplier)
Anti-NoV GII VP1 Neutralizing Antibody (V3S-0522-YC4189) (1 supplier)
